The research for cancer treatment is moving forward at a rapid pace. With over 12.5 million new cases of cancer being identified worldwide each year, improved diagnosis and treatment is essential, yet oncology clinical research remains complex
Special consideration needs to be given to the technical and organizational controls that will ensure safety and minimise risk.
Choosing the right CDMO for the development and production of high potent clinical trial material is key to successfully manage scale-up of products throughout the clinical phases through to successful commercialization.
Join us on Thursday, October 28th for this Watercooler chat to hear how sponsors can reduce complexity and manage their drug development challenges to optimize the supply chain, maintain flexibility and ensure the critical success of bringing these highly specialized medicines to patients in need.
In this watercooler, participants will:
- Learn how to avoid or overcome manufacturing challenges that can have a profound impact on a projects critical parameters, particularly lead time and cost
- Examine innovative and improved packaging methods and tools to address the complexities that traditional packaging methods demonstrate
- Understand the logistical challenges associated with storage and distribution of oncology medicines and the options available to safe guard supply chain custody of their drug product
- Discover the benefits of working with a CDMO right through the drug development journey to provide a seamless transfer to successful commercialization